 Live video webcast on Tuesday, January 17th at 3:00 PM ET Carlsbad, CA, Jan. 09, 2023 GLOBE NEWSWIRE Palisade Bio Nasdaq: PALI, a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal GI complications, today announced that J.D. Finley, Interim Chief Executive Officer of Palisade Bio will present at the Virtual Investor 2023 Companies... The post Palisade Bio to Present at the Virtual Investor 2023 Companies to Watch Event appeared first on DKOD... 